Viewing offline content

Limited functionality available

Dismiss
Deloitte Middle East
  • Services

    What's New

    • Deloitte175

      Join us for a celebration of 175 years of making an impact that matters.

    • Building the Resilient Organization

      2021 Deloitte Global resilience report

    • 2020 Global Gender Impact Report

      A collection of Butterfly Effect stories highlighting how our Deloitte professionals are positively impacting the lives of women and girls around the world

    • Audit & Assurance

      • Assurance
    • Consulting

      • Strategy, Analytics and M&A
      • Customer and Marketing
      • Business Operations
      • Human Capital
      • Enterprise Technology & Performance
    • Financial Advisory

      • Mergers & Acquisitions
      • Forensic
      • Real Estate
      • Turnaround & Restructuring
    • Risk Advisory

      • Strategic & Reputation Risk
      • Regulatory Risk
      • Financial Risk
      • Operational Risk
      • Cyber Risk
    • Tax

      • Global Business Tax Services
      • Indirect Tax
      • Global Employer Services
    • Deloitte Private

      • Family Enterprise
    • Legal

    • Sustainability

  • Industries

    What's New

    • Deloitte perspectives

      Leadership perspectives from across the globe.

    • Deloitte Insights App

      Our thought leadership and Dow Jones news, now at your fingertips

    • Future of Mobility

      Learn how this new reality is coming together and what it will mean for you and your industry.

    • Consumer

      • Automotive
      • Consumer Products
      • Retail, Wholesale & Distribution
      • Transportation, Hospitality & Services
    • Energy, Resources & Industrials

      • Industrial Products & Construction
      • Mining & Metals
      • Oil, Gas & Chemicals
      • Power, Utilities & Renewables
    • Financial Services

      • Banking & Capital Markets
      • Insurance
      • Investment Management
      • Real Estate
    • Government & Public Services

      • Civil Government
      • Defense, Security & Justice
      • Health & Social Care
      • Transport
    • Life Sciences & Health Care

      • Health Care
      • Life Sciences
    • MENA Sovereign Wealth Funds

    • Technology, Media & Telecommunications

      • Technology
      • Telecommunications, Media & Entertainment
  • Insights

    Deloitte Insights

    What's New

    • Deloitte Insights Magazine

      Explore the latest issue now

    • Deloitte Insights app

      Go straight to smart with daily updates on your mobile device

    • Weekly economic update

      See what's happening this week and the impact on your business

    • Strategy

      • Business Strategy & Growth
      • Digital Transformation
      • Governance & Board
      • Innovation
      • Marketing & Sales
      • Private Enterprise
    • Economy & Society

      • Economy
      • Environmental, Social, & Governance
      • Health Equity
      • Trust
      • Mobility
    • Organization

      • Operations
      • Finance & Tax
      • Risk & Regulation
      • Supply Chain
      • Smart Manufacturing
    • People

      • Leadership
      • Talent & Work
      • Diversity, Equity, & Inclusion
    • Technology

      • Data & Analytics
      • Emerging Technologies
      • Technology Management
    • Industries

      • Consumer
      • Energy, Resources, & Industrials
      • Financial Services
      • Government & Public Services
      • Life Sciences & Health Care
      • Technology, Media, & Telecommunications
    • Spotlight

      • Deloitte Insights Magazine
      • Press Room Podcasts
      • Weekly Economic Update
      • COVID-19
      • Resilience
  • Careers

    What's New

    • Millennial Survey 2022

      Gen Zs and millennials are striving for balance and advocating for change.

    • Candidate Profile

      After applying for a job in this country, you can access/update your candidate profile at any time.

    • Job Search

    • Students

    • Experienced Hires

    • Executives

    • Life at Deloitte

    • Alumni

    • Diversity and Inclusion

  • XE-EN Location: XE-English  
  • Contact us
  • XE-EN Location: XE-English  
  • Contact us
    • Dashboard
    • Saved items
    • Content feed
    • Profile/Interests
    • Account settings

Welcome back

Still not a member? Join My Deloitte

Winning in the future of medtech

by Pedro Arboleda, Sonal Shah, Debanshu Mukherjee, Glenn Snyder
  • Save for later
  • Download
  • Share
    • Share on Facebook
    • Share on Twitter
    • Share on Linkedin
    • Share by email
Deloitte Insights
  • Strategy
    Strategy
    Strategy
    • Business Strategy & Growth
    • Digital Transformation
    • Governance & Board
    • Innovation
    • Marketing & Sales
    • Private Enterprise
  • Economy & Society
    Economy & Society
    Economy & Society
    • Economy
    • Environmental, Social, & Governance
    • Health Equity
    • Trust
    • Mobility
  • Organization
    Organization
    Organization
    • Operations
    • Finance & Tax
    • Risk & Regulation
    • Supply Chain
    • Smart Manufacturing
  • People
    People
    People
    • Leadership
    • Talent & Work
    • Diversity, Equity, & Inclusion
  • Technology
    Technology
    Technology
    • Data & Analytics
    • Emerging Technologies
    • Technology Management
  • Industries
    Industries
    Industries
    • Consumer
    • Energy, Resources, & Industrials
    • Financial Services
    • Government & Public Services
    • Life Sciences & Health Care
    • Tech, Media, & Telecom
  • Spotlight
    Spotlight
    Spotlight
    • Deloitte Insights Magazine
    • Press Room Podcasts
    • Weekly Economic Update
    • COVID-19
    • Resilience
    • XE-EN Location: XE-English  
    • Contact us
      • Dashboard
      • Saved items
      • Content feed
      • Profile/Interests
      • Account settings
    4 minute read 19 September 2019

    Winning in the future of medtech Novel partnerships with consumer tech to transform care delivery

    4 minute read 19 September 2019
    • Pedro Arboleda United States
    • Sonal Shah United States
    • Debanshu Mukherjee United States
    • Glenn Snyder United States
    • Glenn Snyder United States
    • Save for later
    • Download
    • Share
      • Share on Facebook
      • Share on Twitter
      • Share on Linkedin
      • Share by email

    Medtech companies are well-positioned to drive the future of health, but most cannot do it alone. They should instead partner with consumer technology and specialized digital health companies to meet the changing market. 

    The future of health is expected to be driven by an omnipresent, proactive, and integrated system of health and well-being where transformational technologies (e.g., artificial intelligence, quantum computing, cloud storage, augmented and virtual reality, and so on) are poised to play a huge role.

    Learn more

    Read the full report

    Learn more about the Future of Health

    Explore the Health care collection

    Subscribe to receive the latest insights

    Download the Deloitte Insights and Dow Jones app

    When it comes to medtech, we expect medical devices to meld hardware and software to allow customers to diagnose and perhaps even treat medical conditions at home. And as health care’s focus moves toward prevention instead of treatment, the future devices may alert care teams about potential health issues before they become symptomatic through always-on sensors. As medtech companies’ business models are likely to change dramatically, they should consider collaborating with technology companies to address the increasingly changing needs and expectations of consumers.

    To find out what the medtech company of the future will look like (and more), the Deloitte Center for Health Solutions conducted a crowdsourcing simulation with experts across digital health startups, medtech companies, technology companies, health plans, health systems, and research institutions.

    One finding from our research is that medtech companies could differentiate themselves through their ability to harness data gathered by their devices and use it to improve well-being, anticipate health issues, and help patients change the day-to-day behaviors that affect their health. In many ways, the data collected from hardware is expected to be more valuable than the hardware itself. Medtech companies, which have traditionally focused on developing hardware (e.g., surgical equipment, joint replacements, diagnostic equipment, infusion pumps, pacemakers, etc.), might have to shift their focus to software, data collection, and data analysis.

     

    This shift in focus from hardware to software would mean that the medtech company of the future will face intense competition from consumer technology companies. They should also deliver products that embrace new care models. They should be prepared to innovate across the complete patient journey. And while there are some areas in which medtech companies are likely to drive innovation, such as robotics, there are others where they should partner, such as virtual reality. 

    Beyond product offerings, medtech companies are also positioned to help hospitals and health systems make the transition to the future of health through services. Medtech companies could play a significant role in reducing medical costs, optimizing surgeon performance, and improving patient outcomes in the near term through services such as remote patient monitoring, data storage and integration, and improving clinical efficiency.

    Medtech companies that successfully incorporate some, or all, of these services can help move the main point of care outside the acute hospital setting and transition the health sector toward prevention and early intervention, a key shift enabling the future of health. 

     

    With such a strong focus on software, medtech companies should consider partnering with consumer-focused technology and specialized digital health companies to stay relevant in the future of health.1 These companies have advanced capabilities, including the ability to collect, store, and analyze vast amounts of health data generated by medical devices (and other sources of vast amounts of data), as well as deep insights on what motivates and engages consumers.

    Medtech companies may have their reservations in treading this path. Possible fears concerning data security and outside players gaining access to their intellectual property (IP) are valid. Our view is that it is possible for them to have proper data security measures in place to protect the Fort Knox that is their IP and join hands with consumer technology companies to create a win-win situation for both. If they choose not to, new entrants and/or their existing competitors likely will.

    Tag-teaming with consumer technology companies can not only help medtech companies to pin down and defeat disease effectively in the future but also enjoy a host of other benefits. In a future that will likely be increasingly customer-centric, partnership with consumer tech companies can help medtech companies get closer to the consumers and gauge their pulse more effectively (literally and figuratively). Besides, medtech companies stand to gain from partnerships with consumer tech companies in terms of a meaningful give-and-take of expertise, improved operational efficiency, a stronger sense of data analysis, enhanced well-being and care delivery, and care enablement. Similarly, although consumer-focused technology companies have access to a large customer footprint and data, they likely lack the deep industry knowledge and the credibility with physicians that leading medtech companies have. Both players could complement one another.


    To learn more about what the future holds for medtech companies and how they can change the future of health together with consumer tech companies, read our full report, Winning in the future of medtech: Novel partnerships with consumer tech to transform care delivery.


    Acknowledgments

    Leslie Korenda managed the project, contributed significantly to the research and analysis, and wrote and edited sections of the report. Leena Gupta supported the interpretation of research and wrote sections of the report. Kyle Sutter led the crowdsourcing simulation. Steve Davis wrote and edited sections of the report.

    The authors would also like to thank Glenn Snyder, Bill Murray, Chris Park, Michael Dohrmann, Jay Zhu, Doug Billings, Neal Batra, Russell Jones, Veronica Lim, Phil Englert, Rob Jacoby, Karen Taylor, Bushra Naaz, Balaji Bondili, Lynn Sherry, Lauren Wallace, Ramani Moses, and the many others who contributed their ideas and insights to this project.

    Cover image by: Taylor Callery

    Topics in this article

    Technology , , Consumer Products , Digital Health , Health Care , Innovation , Life Sciences

    ​The Future of Health

    The health industry is on the cusp of a major transformation that will affect all stakeholders. Incumbent players can either lead this transformation as innovative and well-connected market leaders, or they can try to resist this inevitable change. A wide range of companies—from inside and outside of the health care sector—are already making strategic investments that could form the foundation for a future of health that is defined by radically interoperable data, open and secure platforms, and consumer-driven care.

    Learn more
    Get in touch
    Contact
    • ​Pedro Arboleda
    • Managing director
    • Deloitte Consulting LLP
    • parboleda@deloitte.com
    • +1 617 437 3802

    Download Subscribe

    Related content

    img Trending

    Interactive 3 days ago

    Explore the Future of health care

    • A consumer-driven culture of health Article7 years ago
    • Forces of change in health care Article3 years ago
    • The health plan of tomorrow Article3 years ago
    • Smart health communities and the future of health Article3 years ago
    • The future of aging Article3 years ago
    • Health care Collection
    Pedro Arboleda

    Pedro Arboleda

    Managing Director | Deloitte Consulting LLP

    Pedro Arboleda is a managing director in Deloitte Consulting LLP’s Strategy practice. With 18 years of experience in the Life Sciences industry, Pedro has focused his career on developing commercial and business development strategies for small-cap, mid-cap and multi-billion dollar medical technology companies. He has applied his knowledge of and passion for the convergence of health, predictive data analytics, cognitive technologies, behavioral science, and innovative solutions to transform business models and tackle challenging societal health issues for Deloitte’s medical technology clients.

    • parboleda@deloitte.com
    • +1 617 437 3802
    Sonal Shah

    Sonal Shah

    Senior Manager | Deloitte Services LP

    Sonal is a senior manager with the Deloitte Center for Health Solutions within Deloitte Services LP and leads the center’s life sciences research. Through her research, she helps inform Deloitte’s health care, life sciences, and government clients about emerging trends, challenges, and opportunities. Her research focuses on R&D and innovation, the impact of the ongoing health care transformation to life sciences companies, and value-based care. Prior to Deloitte, Sonal worked in the biopharma industry. Sonal has a Master of Business Administration in health care management from the Wharton School, and a Doctor of Pharmacy from the Rutgers University Ernest Mario School of Pharmacy.

    • sonshah@deloitte.com
    • +1 212 653 6025
    Debanshu Mukherjee

    Debanshu Mukherjee

    Debanshu Mukherjee is a senior analyst with Deloitte Services India Pvt Ltd, affiliated with the Deloitte Center for Health Solutions. He has been with the firm for more than four years, and his research focuses on topics which have current and future relevance to clients in the life sciences and health care industries. Mukherjee holds a master’s degree in biotechnology and enterprise from the University of Manchester and a master’s degree in business administration from ICFAI Business School, Hyderabad.

    • debamukherjee@deloitte.com
    Glenn Snyder

    Glenn Snyder

    Medical Technology Segment Leader

    Glenn leads Deloitte LLP's Medical Technology practice with more than 25 years of experience in medical technology, biotech, and specialty pharmaceuticals. He helps clients grow through organic and inorganic means by entering new geographic markets, and expanding into new product/service areas. Glenn also helps clients improve brand/commercial effectiveness by articulating product economic value, applying innovative pricing, updating the commercial model, and rationalizing distribution networks.

    • gsnyder@deloitte.com
    • +1 415 699 4469

    Share article highlights

    See something interesting? Simply select text and choose how to share it:

    Email a customized link that shows your highlighted text.
    Copy a customized link that shows your highlighted text.
    Copy your highlighted text.

    Winning in the future of medtech has been saved

    Winning in the future of medtech has been removed

    An Article Titled Winning in the future of medtech already exists in Saved items

     
    Forgot password

    To stay logged in, change your functional cookie settings.

    OR

    Social login not available on Microsoft Edge browser at this time.

    Connect Accounts

    Connect your social accounts

    This is the first time you have logged in with a social network.

    You have previously logged in with a different account. To link your accounts, please re-authenticate.

    Log in with an existing social network:

    To connect with your existing account, please enter your password:

    OR

    Log in with an existing site account:

    To connect with your existing account, please enter your password:

    Forgot password

    Subscribe

    to receive more business insights, analysis, and perspectives from Deloitte Insights
    ✓ Link copied to clipboard
    • Contact us
    • Search Jobs
    • Submit RFP
    Follow Deloitte Insights:
    Global office directory Office locations
    XE-EN Location: XE-English  
    About Deloitte
    • Newsroom
    • Deloitte events
    • Our blog collections
    • Press releases
    • Press contacts
    • Corporate Responsibility & Sustainability
    • Report an ethics complaint
    Services
    • Audit & Assurance
    • Consulting
    • Financial Advisory
    • Risk Advisory
    • Tax
    • Deloitte Private
    • Legal
    • Sustainability
    Industries
    • Consumer
    • Energy, Resources & Industrials
    • Financial Services
    • Government & Public Services
    • Life Sciences & Health Care
    • MENA Sovereign Wealth Funds
    • Technology, Media & Telecommunications
    Careers
    • Job Search
    • Students
    • Experienced Hires
    • Executives
    • Life at Deloitte
    • Alumni
    • Diversity and Inclusion
    • About Deloitte
    • About Deloitte in the Middle East
    • Privacy
    • Terms of use
    • Cookies
    • Avature Privacy

    © 2022. See Terms of Use for more information.

    Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see About Deloitte to learn more about our global network of member firms.